UFP Technologies, Inc. (NASDAQ:UFPT – Get Free Report) Director Daniel C. Croteau sold 6,846 shares of the stock in a transaction on Thursday, February 27th. The stock was sold at an average price of $228.41, for a total transaction of $1,563,694.86. Following the transaction, the director now owns 1,785 shares of the company’s stock, valued at $407,711.85. The trade was a 79.32 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
UFP Technologies Price Performance
Shares of UFPT opened at $215.37 on Thursday. The firm has a market capitalization of $1.65 billion, a PE ratio of 30.72 and a beta of 1.04. The company’s 50-day moving average is $254.82 and its 200-day moving average is $287.66. UFP Technologies, Inc. has a fifty-two week low of $188.50 and a fifty-two week high of $366.41. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.57 and a quick ratio of 1.43.
UFP Technologies (NASDAQ:UFPT – Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.45. The company had revenue of $144.07 million for the quarter, compared to analyst estimates of $141.67 million. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%.
Hedge Funds Weigh In On UFP Technologies
Analyst Ratings Changes
Separately, StockNews.com lowered shares of UFP Technologies from a “hold” rating to a “sell” rating in a research report on Thursday, January 23rd.
Check Out Our Latest Analysis on UFPT
About UFP Technologies
UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.
Read More
- Five stocks we like better than UFP Technologies
- How to Invest in the FAANG Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights?
- Investing In Preferred Stock vs. Common Stock
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Trading Stocks: RSI and Why it’s Useful
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for UFP Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UFP Technologies and related companies with MarketBeat.com's FREE daily email newsletter.